Hutchmed
Clinical trials sponsored by Hutchmed, explained in plain language.
-
Experimental IDH drug trial halted early
Disease control TerminatedThis early-stage study tested a new drug, HMPL-306, in 42 adults with advanced solid tumors that have an IDH mutation. The goal was to find a safe dose and check for side effects. The study was terminated early, so results are limited and no cure is expected.
Phase: PHASE1 • Sponsor: Hutchmed • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New pill for tough lymphomas shows early promise, but trial stopped short
Disease control TerminatedThis early-stage trial tested an oral drug called HMPL-523 in 69 people with lymphoma that had returned or stopped responding to other treatments. The main goals were to check safety and find the right dose. The study was terminated early, so we have limited information on how we…
Phase: PHASE1 • Sponsor: Hutchmed • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Experimental IDH drug trial halted early – what we know so far
Disease control TerminatedThis early-stage study tested an experimental drug called HMPL-306 in 46 adults with advanced blood cancers (like leukemia) that have a specific genetic change called an IDH mutation. The goal was to find a safe dose and check for side effects. The study was stopped early, so res…
Phase: PHASE1 • Sponsor: Hutchmed • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC